Skip to main content
. 2021 Sep 30;12:742941. doi: 10.3389/fimmu.2021.742941

Table 1.

Classification of COVID-19.

Classification Mild Moderate Severe Critical Ref.
Signs & symptoms Mild symptoms Fever Respiratory distress ≥30 breaths/min Respiratory failure and requiring mechanical ventilation (9)
Respiratory symptoms Resting SpO2 ≤ 93% Shock
Arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2)≤300mmHg (l mmHg = 0.133 kPa) With another organ failure necessitating ICU care
Imaging No signs of pneumonia Signs of pneumonia present Obvious lesion progression within 24–48h >50% Diffuse pulmonary involvement (“white lung”) (9, 10)
Pathogenesis Increased viral replication Viral replication continues Predominant inflammatory response Inflammatory response (11, 12)
Inflammatory response Reduced viral replication
Therapeutic Intervention Antiviral drugs Antiviral drugs Anti-inflammatory drugs Anti-inflammatory drugs (11, 12)
Antibody therapy Antibody therapy Antiviral drugs